Evolution of Resistant M414T Mutants among Hepatitis C Virus Replicon Cells Treated with Polymerase Inhibitor A-782759

Por Lu, Liangjun, Mo, Hongmei, Pilot-Matias, Tami J., Molla, Akhteruzzaman
Publicado em 2007

Prevalence, Mutation Patterns, and Effects on Protease Inhibitor Susceptibility of the L76V Mutation in HIV-1 Protease

Por Young, Thomas P., Parkin, Neil T., Stawiski, Eric, Pilot-Matias, Tami, Trinh, Roger, Kempf, Dale J., Norton, Michael
Publicado em 2010

Randomized trial of interferon‐ and ribavirin‐free ombitasvir/paritaprevir/ritonavir in treatment‐experienced hepatitis C virus–infected patients

Por Chayama, Kazuaki, Notsumata, Kazuo, Kurosaki, Masayuki, Sato, Ken, Rodrigues, Lino, Setze, Carolyn, Badri, Prajakta, Pilot‐Matias, Tami, Vilchez, Regis A., Kumada, Hiromitsu
Publicado no Hepatology (2015)

Hepatitis C Virus Genotype 4 Resistance and Subtype Demographic Characterization of Patients Treated with Ombitasvir plus Paritaprevir/Ritonavir

Por Schnell, Gretja, Tripathi, Rakesh, Beyer, Jill, Reisch, Thomas, Krishnan, Preethi, Lu, Liangjun, Dekhtyar, Tatyana, Hall, Coleen, Vilchez, Regis A., Pilot-Matias, Tami, Collins, Christine
Publicado no Antimicrob Agents Chemother (2015)

Mutations Conferring Resistance to a Potent Hepatitis C Virus Serine Protease Inhibitor In Vitro

Por Lu, Liangjun, Pilot-Matias, Tami J., Stewart, Kent D., Randolph, John T., Pithawalla, Ron, He, Wenping, Huang, Peggy P., Klein, Larry L., Mo, Hongmei, Molla, Akhteruzzaman
Publicado em 2004

Resistance Analysis of Baseline and Treatment-Emergent Variants in Hepatitis C Virus Genotype 1 in the AVIATOR Study with Paritaprevir-Ritonavir, Ombitasvir, and Dasabuvir

Por Krishnan, Preethi, Tripathi, Rakesh, Schnell, Gretja, Reisch, Thomas, Beyer, Jill, Irvin, Michelle, Xie, Wangang, Larsen, Lois, Cohen, Daniel, Podsadecki, Thomas, Pilot-Matias, Tami, Collins, Christine
Publicado no Antimicrob Agents Chemother (2015)

Molecular and biophysical characterization of TT virus: Evidence for a new virus family infecting humans

Por Mushahwar, Isa K., Erker, James C., Muerhoff, A. Scott, Leary, Thomas P., Simons, John N., Birkenmeyer, Larry G., Chalmers, Michelle L., Pilot-Matias, Tami J., Dexai, Suresh M.
Publicado em 1999

Analysis of Hepatitis C Virus Genotype 1b Resistance Variants in Japanese Patients Treated with Paritaprevir-Ritonavir and Ombitasvir

Por Krishnan, Preethi, Schnell, Gretja, Tripathi, Rakesh, Beyer, Jill, Reisch, Thomas, Zhang, Xinyan, Setze, Carolyn, Rodrigues, Lino, Burroughs, Margaret, Redman, Rebecca, Chayama, Kazuaki, Kumada, Hiromitsu, Collins, Christine, Pilot-Matias, Tami
Publicado no Antimicrob Agents Chemother (2016)

In Vitro and In Vivo Antiviral Activity and Resistance Profile of Ombitasvir, an Inhibitor of Hepatitis C Virus NS5A

Por Krishnan, Preethi, Beyer, Jill, Mistry, Neeta, Koev, Gennadiy, Reisch, Thomas, DeGoey, David, Kati, Warren, Campbell, Andrew, Williams, Laura, Xie, Wangang, Setze, Carolyn, Molla, Akhteruzzaman, Collins, Christine, Pilot-Matias, Tami
Publicado no Antimicrob Agents Chemother (2015)

Integrated Resistance Analysis of CERTAIN-1 and CERTAIN-2 Studies in Hepatitis C Virus-Infected Patients Receiving Glecaprevir and Pibrentasvir in Japan

Por Krishnan, Preethi, Schnell, Gretja, Tripathi, Rakesh, Beyer, Jill, Reisch, Thomas, Dekhtyar, Tatyana, Irvin, Michelle, Xie, Wangang, Fu, Bo, Burroughs, Margaret, Redman, Rebecca, Kumada, Hiromitsu, Chayama, Kazuaki, Collins, Christine, Pilot-Matias, Tami
Publicado no Antimicrob Agents Chemother (2018)

In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir

Por Ng, Teresa I., Krishnan, Preethi, Pilot-Matias, Tami, Kati, Warren, Schnell, Gretja, Beyer, Jill, Reisch, Thomas, Lu, Liangjun, Dekhtyar, Tatyana, Irvin, Michelle, Tripathi, Rakesh, Maring, Clarence, Randolph, John T., Wagner, Rolf, Collins, Christine
Publicado no Antimicrob Agents Chemother (2017)

Mutations Conferring Resistance to a Hepatitis C Virus (HCV) RNA-Dependent RNA Polymerase Inhibitor Alone or in Combination with an HCV Serine Protease Inhibitor In Vitro

Por Mo, Hongmei, Lu, Liangjun, Pilot-Matias, Tami, Pithawalla, Ron, Mondal, Rubina, Masse, Sherie, Dekhtyar, Tatyana, Ng, Teresa, Koev, Gennadiy, Stoll, Vincent, Stewart, Kent D., Pratt, John, Donner, Pam, Rockway, Todd, Maring, Clarence, Molla, Akhteruzzaman
Publicado em 2005

Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for hepatitis C virus genotype 1b–infected Japanese patients with or without cirrhosis

Por Kumada, Hiromitsu, Chayama, Kazuaki, Rodrigues, Lino, Suzuki, Fumitaka, Ikeda, Kenji, Toyoda, Hidenori, Sato, Ken, Karino, Yoshiyasu, Matsuzaki, Yasushi, Kioka, Kiyohide, Setze, Carolyn, Pilot‐Matias, Tami, Patwardhan, Meenal, Vilchez, Regis A., Burroughs, Margaret, Redman, Rebecca
Publicado no Hepatology (2015)

In Vitro and In Vivo Antiviral Activity and Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor ABT-450

Por Pilot-Matias, Tami, Tripathi, Rakesh, Cohen, Daniel, Gaultier, Isabelle, Dekhtyar, Tatyana, Lu, Liangjun, Reisch, Thomas, Irvin, Michelle, Hopkins, Todd, Pithawalla, Ron, Middleton, Timothy, Ng, Teresa, McDaniel, Keith, Or, Yat Sun, Menon, Rajeev, Kempf, Dale, Molla, Akhteruzzaman, Collins, Christine
Publicado no Antimicrob Agents Chemother (2015)

Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial

Por Wyles, David, Poordad, Fred, Wang, Stanley, Alric, Laurent, Felizarta, Franco, Kwo, Paul Y., Maliakkal, Benedict, Agarwal, Kosh, Hassanein, Tarek, Weilert, Frank, Lee, Samuel S., Kort, Jens, Lovell, Sandra S., Liu, Ran, Lin, Chih‐Wei, Pilot‐Matias, Tami, Krishnan, Preethi, Mensa, Federico J.
Publicado no Hepatology (2018)

Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection

Por Kumada, Hiromitsu, Watanabe, Tsunamasa, Suzuki, Fumitaka, Ikeda, Kenji, Sato, Ken, Toyoda, Hidenori, Atsukawa, Masanori, Ido, Akio, Takaki, Akinobu, Enomoto, Nobuyuki, Kato, Koji, Alves, Katia, Burroughs, Margaret, Redman, Rebecca, Pugatch, David, Pilot-Matias, Tami J., Krishnan, Preethi, Oberoi, Rajneet K., Xie, Wangang, Chayama, Kazuaki
Publicado no J Gastroenterol (2017)

Correction to: Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection

Por Kumada, Hiromitsu, Watanabe, Tsunamasa, Suzuki, Fumitaka, Ikeda, Kenji, Sato, Ken, Toyoda, Hidenori, Atsukawa, Masanori, Ido, Akio, Takaki, Akinobu, Enomoto, Nobuyuki, Kato, Koji, Alves, Katia, Burroughs, Margaret, Redman, Rebecca, Pugatch, David, Pilot-Matias, Tami J., Krishnan, Preethi, Oberoi, Rajneet K., Xie, Wangang, Chayama, Kazuaki
Publicado no J Gastroenterol (2017)

In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir

Por Ng, Teresa I., Tripathi, Rakesh, Reisch, Thomas, Lu, Liangjun, Middleton, Timothy, Hopkins, Todd A., Pithawalla, Ron, Irvin, Michelle, Dekhtyar, Tatyana, Krishnan, Preethi, Schnell, Gretja, Beyer, Jill, McDaniel, Keith F., Ma, Jun, Wang, Guoqiang, Jiang, Li-Juan, Or, Yat Sun, Kempf, Dale, Pilot-Matias, Tami, Collins, Christine
Publicado no Antimicrob Agents Chemother (2017)

Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection

Por Toyoda, Hidenori, Chayama, Kazuaki, Suzuki, Fumitaka, Sato, Ken, Atarashi, Tomofumi, Watanabe, Tsunamasa, Atsukawa, Masanori, Naganuma, Atsushi, Notsumata, Kazuo, Osaki, Yukio, Nakamuta, Makoto, Takaguchi, Koichi, Saito, Satoru, Kato, Koji, Pugatch, David, Burroughs, Margaret, Redman, Rebecca, Alves, Katia, Pilot‐Matias, Tami J., Oberoi, Rajneet K., Fu, Bo, Kumada, Hiromitsu
Publicado no Hepatology (2017)

Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis

Por Chayama, Kazuaki, Suzuki, Fumitaka, Karino, Yoshiyasu, Kawakami, Yoshiiku, Sato, Ken, Atarashi, Tomofumi, Naganuma, Atsushi, Watanabe, Tsunamasa, Eguchi, Yuichiro, Yoshiji, Hitoshi, Seike, Masataka, Takei, Yoshiyuki, Kato, Koji, Alves, Katia, Burroughs, Margaret, Redman, Rebecca, Pugatch, David L., Pilot-Matias, Tami J., Krishnan, Preethi, Oberoi, Rajneet K., Xie, Wangang, Kumada, Hiromitsu
Publicado no J Gastroenterol (2017)